Effect of erlotinib adjuvant therapy in serum VEGF and prognosis in patients with pancreatic cancer

doi:10.3969/j.issn.1672-3384.2017.09.015

PDF(528 KB)

Clinical Medication Journal ›› 2017, Vol. 15 ›› Issue (9) : 62-65. DOI: 10.3969/j.issn.1672-3384.2017.09.015

Original Paper

Effect of erlotinib adjuvant therapy in serum VEGF and prognosis in patients with pancreatic cancer

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2017, 15(9): 62-65 https://doi.org/10.3969/j.issn.1672-3384.2017.09.015

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(528 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2017-07-07	2017-09-25
Issue Date
2017-09-25

Please choose a citation manager

Content to export